Smart Ring Rivals Are Circling as Oura Heads Toward a Public Offering
Oura is filing for an IPO, but Ultrahuman, RingConn, and others are building serious competition in the fast-growing smart ring market.
Read More
Generic Biologics Are About to Become a $70 Billion Industry — and Patent Cliffs Are the Reason Why
The global biosimilars market is projected to hit $70.79 billion by 2036, driven by patent expirations and rising demand for affordable biologics.
A Nonprofit Acquires Its First K-12 Platform, Betting Wayfinder Can Redefine Student Career Readiness
A fast-growing public charity acquires Wayfinder, marking its first K-12 deal and a major push into student career and life-skills readiness.
Nscale Chases $3.5 Billion Before Going Public as AI Infrastructure Spending Shows No Signs of Cooling
AI compute provider Nscale is seeking $3.5B in pre-IPO financing, signaling massive investor appetite for GPU cloud infrastructure.
Nvidia Pays $13 Billion for Hugging Face, Turning AI’s Open-Source Heartbeat Into a Corporate Asset
Nvidia acquires Hugging Face for $13 billion, ending the open-source AI platform’s run as an independent force in machine learning.
A New Tool Lets You See Exactly Which Data Brokers Are Selling Your Personal Information
A new free service exposes which data brokers are trading your personal data — and gives you a direct path to opt out.
Oura Files for US IPO as Annual Revenue Climbs Past $500 Million
Oura’s IPO filing reveals rapid revenue growth, a $5.2B valuation, and ambitions to reshape the wearable health tech market.
Forget Consciousness: The Real Question Is Whether AI Has Crossed Into Something Like Life
A provocative new argument shifts the AI sentience debate away from consciousness entirely — and toward whether AI systems already qualify as alive.
When AI Does the Hard Work, Who Learns the Hard Lessons?
AI tools are making engineers faster — but experts warn the productivity gains may be quietly hollowing out deep technical expertise.
A Mass Diarrhea Outbreak in 150 Monkeys Accidentally Generated a Treasure Trove of Vaccine Science
When 150 research primates fell ill with diarrhea, scientists turned the crisis into a rare, expansive dataset on immune response and vaccine efficacy.